Figure 1. Alb-Cre-driven NS deletion causes liver damage associated with bile duct hyperplasia.
(A) (Top) Northern blots show a significant upregulation of NS transcripts in CCl4-injured livers (8-week-old). The increase of NS peaks on the first day of the injection. (Bottom) the percentage of BrdU-labeled hepatocytes reaches plateau on the second day of the injection. (B) Southern blots (hybridized with 5’-probe or 3’-probe) confirm the genotypes of the NSflxneo and NSflx alleles. (C) qRT-PCR assays verify the decrease of NS (top) and the increase of Cre (bottom) in albNScko livers compared to age-matched NSflx/flx livers from 1 to 4 weeks old. (D) At 4 weeks, albNScko livers display a nodular appearance. (E1) The H&E histology of 4-week-old albNScko livers shows hepatic lobules surrounded by hyperplastic bile ducts. Insets show enlarged images of the rectangles. (E2) These hyperplastic bile ducts express CK-19. Bottom panels show images of NSflx/flx livers. (E3) From 3 weeks of age, necrotic foci can be seen in the albNScko liver parenchyma. The bottom panel shows an enlarged view of the rectangular region in the top panel. (F) The liver-to-body weight ratio of albNScko mice increases over that of NSflx/flx mice from 3 weeks old. Bar and line graphs represent mean ± SEM. *, p < 0.01, **, p < 0.001, ***, p < 0.0001. Scale bars, 100um in (E1, E2, E3 top) and 25um in (E3 bottom).